Oscar Health, Inc.
$16.44
▲
1.62%
2026-04-21 08:41:00
www.hioscar.com
NYQ: OSCR
Explore Oscar Health, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$4.9 B
Current Price
$16.44
52W High / Low
$23.8 / $10.69
Stock P/E
—
Book Value
$3.29
Dividend Yield
—
ROCE
—
ROE
-44.35%
Face Value
—
EPS
$-1.69
Exp Qtr EPS
—
Sector
Healthcare
Industry
Healthcare Plans
Employees
2,305
Beta
1.93
Debt / Equity
50.86
Current Ratio
0.95
Quick Ratio
—
Forward P/E
10.74
Price / Sales
0.37
Enterprise Value
$809.18 M
EV / EBITDA
-2.2
EV / Revenue
0.07
Rating
None
Target Price
$15.4
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Molina Healthcare, Inc. | $153.28 | 17.21 | $8.02 B | — | 9.53% | 11.02% | $333.22 / $121.06 | $79.78 |
| 2. | CVS Health Corporation | $77.63 | 55.78 | $99.22 B | 3.47% | 6.3% | 2.29% | $85.15 / $58.35 | $59.18 |
| 3. | Alignment Healthcare, Inc. | $21.56 | — | $4.34 B | — | 2.9% | -0.7% | $23.87 / $11.62 | $0.88 |
| 4. | Clover Health Investments, Corp. | $2.23 | — | $1.15 B | — | -25.75% | -26.33% | $3.92 / $1.58 | $0.59 |
| 5. | Humana Inc. | $216 | 21.97 | $26.04 B | 1.68% | — | 7.04% | $315.35 / $163.11 | $146.42 |
| 6. | UnitedHealth Group Incorporated | $354.97 | 26.8 | $323.02 B | 2.73% | 9.74% | 12.54% | $489.79 / $234.6 | $103.87 |
| 7. | Progyny, Inc. | $18.64 | 24.25 | $1.42 B | — | 15.79% | 12.48% | $28.75 / $16.1 | $6.24 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 2.81 B | 2.99 B | 2.86 B | 3.05 B | 2.39 B | — |
| Operating Profit | -353.78 M | -132.43 M | -227.69 M | 294.2 M | -147.66 M | — |
| Net Profit | -352.61 M | -137.45 M | -228.36 M | 275.27 M | -153.55 M | — |
| EPS in Rs | -1.35 | -0.52 | -0.87 | 1.05 | -0.59 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 11.7 B | 9.18 B | 5.86 B | 4.13 B |
| Operating Profit | -419.7 M | 57.16 M | -242.7 M | -587.45 M |
| Net Profit | -443.15 M | 25.43 M | -270.73 M | -606.27 M |
| EPS in Rs | -1.69 | 0.1 | -1.03 | -2.31 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 6.33 B | 4.84 B | 3.6 B | 4.53 B |
| Total Liabilities | 5.34 B | 3.82 B | 2.8 B | 3.63 B |
| Equity | 977.65 M | 1.01 B | 803.97 M | 890.38 M |
| Current Assets | — | — | — | — |
| Current Liabilities | — | — | — | — |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 1.09 B | 978.19 M | -272.16 M | 380.35 M |
| Investing CF | -241.06 M | -1.39 B | 577.19 M | -226.52 M |
| Financing CF | 399.21 M | 68.39 M | 6.45 M | 301.11 M |
| Free CF | 1.06 B | 950.3 M | -297.74 M | 351.34 M |
| Capex | -36.37 M | -27.9 M | -25.58 M | -29.01 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 56.54% | 42.11% | — | — |
| Earnings Growth % | 109.39% | 55.35% | — | — |
| Profit Margin % | 0.28% | -4.62% | -14.7% | — |
| Operating Margin % | 0.62% | -4.14% | -14.24% | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.